These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 2401475

  • 41. A reevaluation of the clinical characteristics of clozapine-induced agranulocytosis in light of the United States experience.
    Alvir JM, Lieberman JA.
    J Clin Psychopharmacol; 1994 Apr; 14(2):87-9. PubMed ID: 8195462
    [No Abstract] [Full Text] [Related]

  • 42. Successful treatment of clozapine-induced agranulocytosis with granulocyte colony-stimulating factor.
    Raison CL, Guze BH, Kissell RL.
    J Clin Psychopharmacol; 1994 Aug; 14(4):285-6. PubMed ID: 7525662
    [No Abstract] [Full Text] [Related]

  • 43. Sandoz guidelines for clozapine monitoring called too restrictive.
    Hosp Community Psychiatry; 1991 May; 42(5):545. PubMed ID: 2060927
    [No Abstract] [Full Text] [Related]

  • 44. A review of clozapine: an antipsychotic for treatment-resistant schizophrenia.
    Stephens P.
    Compr Psychiatry; 1990 May; 31(4):315-26. PubMed ID: 2201482
    [Abstract] [Full Text] [Related]

  • 45. Clozapine: is another view valid?
    Meltzer HY.
    Am J Psychiatry; 1995 Jun; 152(6):821-5. PubMed ID: 7755109
    [No Abstract] [Full Text] [Related]

  • 46. Clozapine-induced eosinophilia and switch to quetiapine in a patient with chronic schizophrenia with suicidal tendencies.
    Zipris P, Melamed Y, Weizman A, Bleich A.
    Isr J Psychiatry Relat Sci; 2007 Jun; 44(1):54-6. PubMed ID: 17665812
    [Abstract] [Full Text] [Related]

  • 47. Optimizing clozapine treatment.
    Naber D.
    J Clin Psychiatry; 1999 Jun; 60 Suppl 12():35-8. PubMed ID: 10372609
    [Abstract] [Full Text] [Related]

  • 48. Human leukocyte antigen typing, response to neuroleptics, and clozapine-induced agranulocytosis in jewish Israeli schizophrenic patients.
    Meged S, Stein D, Sitrota P, Melamed Y, Elizur A, Shmuelian I, Gazit E.
    Int Clin Psychopharmacol; 1999 Sep; 14(5):305-12. PubMed ID: 10529073
    [Abstract] [Full Text] [Related]

  • 49. Clozapine.
    Lancet; 1989 Dec 16; 2(8677):1430-2. PubMed ID: 2574365
    [No Abstract] [Full Text] [Related]

  • 50. Letter: Clozapine and agranulocytosis.
    Idänpään-Heikkilä J, Alhava E, Olkinuora M, Palva I.
    Lancet; 1975 Sep 27; 2(7935):611. PubMed ID: 51442
    [No Abstract] [Full Text] [Related]

  • 51. Who should receive clozapine?
    Marder SR, Van Putten T.
    Arch Gen Psychiatry; 1988 Sep 27; 45(9):865-7. PubMed ID: 2901253
    [No Abstract] [Full Text] [Related]

  • 52. [Clozapine and agranulocytosis].
    Xu SH.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1984 Oct 27; 17(5):271-2. PubMed ID: 6537285
    [No Abstract] [Full Text] [Related]

  • 53. [Leponex: experience of the hospital pharmacist].
    Gury C, Dechelette N, Gayral P.
    Encephale; 1995 Jun 27; 21 Spec No 3():61-5. PubMed ID: 7628345
    [Abstract] [Full Text] [Related]

  • 54. Suicide in schizophrenia, clozapine, and adoption of evidence-based medicine.
    Meltzer HY.
    J Clin Psychiatry; 2005 Apr 27; 66(4):530-3. PubMed ID: 15816797
    [No Abstract] [Full Text] [Related]

  • 55. Prevention of clozapine-induced granulocytopenia/agranulocytosis with granulocyte-colony stimulating factor (G-CSF) in an intellectually disabled patient with schizophrenia.
    Rajagopal G, Graham JG, Haut FF.
    J Intellect Disabil Res; 2007 Jan 27; 51(Pt 1):82-5. PubMed ID: 17181606
    [Abstract] [Full Text] [Related]

  • 56. Pharmacokinetic studies of antipsychotics in healthy volunteers versus patients.
    Cutler NR.
    J Clin Psychiatry; 2001 Jan 27; 62 Suppl 5():10-3; discussion 23-4. PubMed ID: 11305842
    [Abstract] [Full Text] [Related]

  • 57. A two-year clinical and economic follow-up of patients on clozapine.
    Honigfeld G, Patin J.
    Hosp Community Psychiatry; 1990 Aug 27; 41(8):882-5. PubMed ID: 2401478
    [Abstract] [Full Text] [Related]

  • 58. Clozapine: benefits and risks.
    Fuchs AM.
    Schizophr Bull; 1994 Aug 27; 20(1):23-4. PubMed ID: 8197418
    [No Abstract] [Full Text] [Related]

  • 59. Agranulocytosis during treatment with chlozapine.
    Idänpään-Heikkilä J, Alhava E, Olkinuora M, Palva IP.
    Eur J Clin Pharmacol; 1977 Mar 11; 11(3):193-8. PubMed ID: 856603
    [Abstract] [Full Text] [Related]

  • 60. Haematological side effects of clozapine: patient characteristics.
    Miller PR, Cutten AE.
    N Z Med J; 1997 Apr 11; 110(1041):125-7. PubMed ID: 9140414
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.